for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

American Renal Associates Holdings Inc

ARA

Latest Trade

6.85USD

Change

-0.05(-0.72%)

Volume

15,532

Today's Range

6.75

 - 

6.99

52 Week Range

5.57

 - 

10.60

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
6.90
Open
6.99
Volume
15,532
3M AVG Volume
1.32
Today's High
6.99
Today's Low
6.75
52 Week High
10.60
52 Week Low
5.57
Shares Out (MIL)
34.61
Market Cap (MIL)
231.18
Forward P/E
-41.75
Dividend (Yield %)
--

Next Event

Q3 2020 American Renal Associates Holdings Inc Earnings Release

Latest Developments

More

American Renal Associates Holdings Reports Qtrly Earnings Per Share $0.01

American Renal Associates Announces First Quarter 2020 Results

American Renal Associates Reports Q4 Adjusted EPS Of $0.19

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About American Renal Associates Holdings Inc

American Renal Associates Holdings, Inc. is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia. The Company operates its dialysis clinics exclusively through a JV model, in which it partners primarily with local nephrologists to develop, own and operate dialysis clinics, while the providers of the majority of dialysis services in the United States operate through a combination of subsidiaries and joint ventures. It provides patient care and clinical outcomes to patients suffering from end-stage renal disease (ESRD). Its clinics offer both in center and home dialysis options to meet the needs of patients. Its clinics primarily provide in center hemodialysis treatments and ancillary items and services.

Industry

Healthcare Facilities

Contact Info

American Renal Holdings

Inc., 500 Cummings Center, Suite 6550

BEVERLY, MA

01915

United States

+1.978.9223080

http://ir.americanrenal.com/

Executive Leadership

Joseph A. Carlucci

Chairman of the Board, Chief Executive Officer, Co-Founder

Syed T. Kamal

President, Co-Founder, Director

Mark C. Herbers

Interim Chief Financial Officer, Interim Chief Accounting Officer

Don Williamson

Chief Operating Officer, Executive Vice President

Michael E. Boxer

Independent Director

Key Stats

3.00 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.7K

2018

0.8K

2019

0.8K

2020(E)

0.8K
EPS (USD)

2017

0.610

2018

0.590

2019

0.260

2020(E)

-0.160
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.28
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
2.91
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
6.23
Return on Equity (TTM)
3.29

Latest News

Latest News

American Renal to settle shareholder lawsuit for nearly $5.78 million

Dialysis provider American Renal Associates Holdings Inc has agreed to pay nearly $5.78 million to resolve a proposed class action alleging it failed to properly account for its revenues and misrepresented key accounting metrics to investors.

BRIEF-American Renal Associates Announces First Quarter 2020 Results

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS

BRIEF-American Renal Associates Reports Changes To Board Of Directors

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

BRIEF-American Renal Associates Holdings Reports Q1 Adjusted Earnings Per Share $0.11

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS

BRIEF-United Healthcare Insurance Co And United Healthcare Services Files Complaint Against American Renal Associates

* ON MARCH 30, UNITED HEALTHCARE INSURANCE CO AND UNITED HEALTHCARE SERVICES FILED A COMPLAINT AGAINST UNITS

BRIEF-American Renal Associates Holdings Qtrly EPS $0.05

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FOURTH QUARTER 2017 RESULTS

BRIEF-American Renal Associates Settles Shareholder Class Action Litigation

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES SETTLEMENT OF SHAREHOLDER CLASS ACTION LITIGATION

BRIEF-American Renal Associates Holdings reports adj. EPS $0.19

* Q3 earnings per share view $0.16 -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up